A review of the device history record confirmed that the device was manufactured and tested according to relevant procedures, and shipped according to manufacturer's specifications.Patient (b)(6) index procedure was performed on (b)(6) 2022.During monitoring, as part of the pas study, apifix identified from patient (b)(6) medical records that on (b)(6) 2022 a wound complication (dehiscence) was identified, a culture was obtained.The patient was hospitalized for spine wound exploration, irrigation, debridement and wound closure following the dehiscence.Iv ancef antibiotics were given.The patient was discharged the next day.The risk of wound complication is a known risk.The event of wound complication is addressed in the ifu (dms-4472 rev g) as potential risks associated with the mid-c system and spinal surgery generally section.The current rate of this event is well in line with the rate reported in the literature for this type of complication as described in the company's cer (clinical evaluation report).The risk has been quantified, characterized, and documented as acceptable within a full risk assessment.
|
Patient (b)(6) index procedure was performed on (b)(6) 2022.During monitoring, as part of the pas study, apifix identified from patient (b)(6) medical records that on (b)(6) 2022 a wound complication (dehiscence) was identified, a culture was obtained.The patient was hospitalized for spine wound exploration, irrigation, debridement and wound closure following the dehiscence.Iv ancef antibiotics were given.The patient was discharged the next day.
|